News and Announcements
Elixinol signs exclusive distribution agreement for Belgium and Luxembourg
- Published August 29, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Elixinol Global Limited is pleased to announce that its Dutch-based wholly-owned subsidiary, Elixinol BV (Elixinol), has signed an exclusive distribution agreement with 25th Group (Distributor) for retail channels in Belgium and Luxembourg.
Under the terms of the exclusive distribution agreement, the Distributor will sell Elixinol branded products via various retail channels for a period of five years.
The exclusivity of the distribution agreement is based on achievement of minimum annual sales targets. Should the sales targets not be met the distribution agreement will become co-exclusive. In addition, the Distributor will be appointed co-exclusive for retail channels including specialty and national retailers in the Netherlands and Switzerland.
This exclusive distribution agreement with 25th Group, as well as the previously announced exclusive distribution agreement with MedVec for the German pharmacy channel, builds on the initiatives Elixinol Global announced 5 February 2019 with expansion of European operations to leverage the significant opportunity within the European hemp and cannabis market.
Elixinol Global Chief Executive Officer, Mr Stratos Karousos, said: “The distribution agreement with 25th Group allows Elixinol to establish a dominant position across central Europe and launch Elixinol branded products throughout retail channels in Benelux and Switzerland.”
Chief Commercial Officer at 25th Group and Managing Partner of Belgian-based CBD Distribution, Mr Joeri Perneel, said: “At this dynamic time for CBD growth across Europe, we are very excited to partner with Elixinol. We have a wealth of experience launching and growing trusted global brands in Switzerland and the Benelux countries where local presence is a vital ingredient. With Elixinol’s exciting range of next-generation products, we are confident in making Elixinol the most trusted CBD brand across the region.”
About Elixinol Global (ASX: EXL)
Elixinol Global Limited is a global leader in the cannabis industry, selling hemp-derived CBD dietary supplements, hemp food and wellness products, as well as holding a manufacturing licence for medicinal cannabis products.
Company Updates
Forget Startups: Why Magnetic Alliance is Betting on “Boring” Mid-Market Turnarounds
While Australia’s venture capital scene spent years chasing unprofitable tech startups and speculative high-growth plays, Mark Lim was quietly taking a radically different path. The Managing Partner of Magnetic Alliance Capital sees the nation’s richest investment opportunities hiding in plain sight: inside thousands of unglamorous, profitable, but operationally sluggish mid-market businesses. Speaking on Wholesale Investor’s […]
The asset class where the market has no vote
Litigation funding returns are decided in a courtroom, not a cycle. Knightsbridge’s Head of Capital is careful to call that a different risk rather than a lower one, and his answer to it is spread, not concentration. Most alternative assets still answer to something. Property answers to rates. Private credit answers to defaults. Even the […]
The listing fee vendors pay whether the house sells or not
Australia’s property portals collect more than $2 billion a year while national listings sit flat. An Australian-built AI platform is targeting the economics, not just the interface. An Australian vendor listing a home pays a vendor-paid advertising fee on top of agency commission. Rama Dwarapudi, Founder and Chief Executive Officer of RealSearch, puts a typical […]
Backed By Leading Investment Groups and Family Offices
